AHI — Advanced Health Intelligence Income Statement
0.000.00%
TechnologyHighly SpeculativeMicro Cap
Annual income statement for Advanced Health Intelligence, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.667 | 1.24 | 0.598 | 2.79 | 2.68 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6.59 | 15.7 | 24 | 13.6 | 6.37 |
Operating Profit | -5.92 | -14.4 | -23.4 | -10.8 | -3.68 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -6.06 | -14.8 | -23.5 | -12.8 | -4.15 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.4 | -14.1 | -22.6 | -12.8 | -4.15 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.4 | -14.1 | -22.6 | -12.8 | -4.15 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.4 | -14.1 | -22.6 | -12.8 | -4.15 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.052 | -0.098 | -0.13 | -0.067 | -0.037 |